Dave Daly joined Foundation Medicine in December 2014 with more than two decades of results-driven commercial diagnostics expertise and a demonstrated track record in building brands and accelerating product adoption in key markets around the world.
Dave served most recently as vice president, commercial operations, Anatomic Pathology Division at Thermo Fisher Scientific. He joined Thermo Fisher Scientific following Thermo’s acquisition of Life Technologies where he served as Head of Oncology, Medical Sciences. Prior to Life Technologies, Dave held a variety of leadership roles for Clarient, Inc., ultimately serving as its chief commercial officer. During his Clarient tenure, he delivered multiple successive years of annual sales growth, exceeding sales quotas and supporting the successful acquisition of Clarient by GE Healthcare. Prior to Clarient /GE Healthcare, Dave served in various sales and marketing leadership roles in molecular diagnostics, hematology, and laboratory automation with Roche Diagnostics and Abbott Laboratories.
Dave holds a Bachelor of Arts degree and a Master’s degree in economics from the University of California, Irvine and Santa Barbara, respectively.